influenza
viru
present
major
threat
human
health
entri
influenza
viru
host
cell
believ
mediat
hemagglutinin
ha
viru
surfac
glycoprotein
bind
termin
sialic
acid
residu
host
cell
glycoprotein
glycolipid
studi
elucid
pathway
enter
human
lung
carcinoma
cell
line
first
prove
enter
cell
via
endocytosi
lysosomotrop
agent
bafilomycin
chloroquin
rescu
cell
death
use
specif
inhibitor
sirna
target
clathrin
pathway
found
could
enter
cell
via
clathrinmedi
endocytosi
inhibitor
target
caveolaemedi
endocytosi
could
inhibit
cell
entri
find
expand
understand
pathogenesi
provid
new
inform
antivir
drug
research
influenza
endocytosi
lysosomotrop
agent
clathrin
studi
elucid
pathway
enter
human
lung
carcinoma
cell
line
first
prove
enter
cell
via
endocytosi
lysosomotrop
agent
bafilomycin
chloroquin
rescu
cell
death
use
specif
inhibitor
sirna
target
clathrin
pathway
found
could
enter
cell
via
clathrinmedi
endocytosi
inhibitor
target
caveolaemedi
endocytosi
could
inhibit
cell
entri
find
expand
understand
pathogenesi
provid
new
inform
antivir
drug
research
influenza
endocytosi
lysosomotrop
agent
clathrin
recent
outbreak
highli
pathogen
avian
influenza
poultri
human
rais
concern
pandem
occur
near
futur
first
isol
patient
hong
kong
sinc
circul
bird
spread
larg
part
world
sporad
human
infect
march
case
human
infect
report
fatal
cumul
case
fatal
rate
http
wwwwho
intcsrdiseaseavianinfluenzacountrycasest
sinc
effect
drug
vaccin
infect
health
profession
cdc
believ
question
go
anoth
avian
influenza
pandem
occur
entri
envelop
virus
target
cell
either
direct
membran
fusion
cell
surfac
via
endocytosi
virus
need
endocytosi
entri
like
use
one
variou
pathway
endocytosi
proven
endocyt
pathway
virus
employ
includ
clathrinmedi
endocytosi
caveolaelipid
raftsmedi
endocytosi
macropinocytosi
nonclathrin
noncaveolaedepend
endocytosi
well
defin
among
pathway
clathrinmedi
endocytosi
commonli
observ
uptak
pathway
virus
bind
receptor
viru
sequest
clathrinco
pit
intern
receptormedi
endocytosi
clathrinco
vesicl
deliv
endosom
viru
penetr
acid
milieu
viru
surfac
glycoprotein
hemagglutinin
ha
believ
mediat
influenza
viru
entri
host
cell
bind
termin
sialic
acid
residu
host
cell
surfac
mediat
fusion
viral
membran
cellular
membran
within
acid
compart
within
cell
mechan
influenza
viru
entri
wide
studi
howev
studi
carri
viru
strain
studi
use
canin
kidney
cell
line
mdck
report
influenza
viru
enter
cell
via
clathrinmedi
endocytosi
caveolaemedi
endocytosi
nonclathrin
noncaveolaedepend
endocytosi
depend
differ
cell
line
viru
strain
use
howev
sinc
risk
pandem
increas
due
widespread
occurr
bird
infect
lack
effect
drug
vaccin
imper
understand
mechan
diseas
caus
human
studi
use
strain
cell
line
human
lung
tissu
main
target
infect
found
viru
enter
human
lung
carcinoma
cell
line
via
clathrindepend
endocytosi
human
lung
adenocarcinoma
cell
line
purchas
atcc
cultur
hyclon
medium
supplement
fb
uml
penicillinstreptomycin
carbon
dioxid
influenza
viru
use
studi
viru
professor
jin
ningyi
institut
militari
veterinari
medicin
academi
militari
medic
scienc
changchun
china
viru
inocul
spf
embryon
fowl
egg
allanto
rout
hemagglutin
allanto
fluid
collect
egg
viru
inactiv
use
formaldehyd
cell
seed
cellsml
one
day
treat
either
indic
amount
inactiv
equal
volum
vehicl
indic
time
cell
viabil
determin
celltit
aqueou
one
solut
cell
prolifer
assay
promega
accord
manufactur
instruct
drug
inhibit
experi
perform
previous
describ
briefli
cell
pretreat
indic
amount
chloroquin
bafilomycin
chlorpromazin
cpz
nystatin
filipin
sigmaaldrich
h
incub
inactiv
h
cell
viabil
determin
describ
cell
transfect
sirna
either
clathrin
heavi
chain
chc
control
sirna
use
lipofectamin
rnaimax
transfect
reagent
invitrogen
accord
manufactur
instruct
h
cell
trypsin
reseed
anoth
h
cell
treat
inactiv
viru
cell
viabil
determin
describ
elimin
nonspecif
knockdown
effect
sirna
sirna
two
manufactur
use
one
santa
cruz
biotechnolog
synthes
guangzhou
ribobio
co
ltd
target
sequenc
effect
sirna
knockdown
determin
h
sirna
transfect
western
blot
use
clathrin
heavi
chain
antibodi
santa
cruz
biotechnolog
cell
plate
coverslip
day
use
cell
mock
treat
pretreat
describ
incub
cholera
toxin
subunit
b
ctb
conjug
invitrogen
min
cell
transfer
anoth
min
cell
wash
moll
glycin
moll
nacl
ph
fix
analyz
confoc
microscop
leica
tc
specif
pmt
adjust
use
imag
captur
use
oil
object
planapo
room
temperatur
confoc
acquisit
softwar
lc
leica
data
shown
mean
sd
statist
analys
conduct
use
twotail
student
ttest
report
influenza
viru
induc
cell
death
numer
cell
type
degre
extent
cell
toxic
caus
influenza
viru
may
vari
depend
specif
cell
type
viru
strain
determin
whether
strain
caus
cell
death
first
incub
cell
inactiv
viru
measur
cell
viabil
mtt
found
strain
caus
cell
death
doseand
timedepend
manner
figur
b
entri
envelop
virus
host
cell
either
endocytosi
direct
membran
fusion
endocyt
entri
pathway
endocytos
virion
typic
subject
acid
ph
result
fusion
viral
membran
endosom
membran
releas
viral
genom
cytosol
therefor
endocyt
pathway
usual
thought
phsensit
direct
membran
fusion
pathway
usual
phindepend
determin
whether
cell
death
relat
endocytosi
pretreat
cell
lysosomotrop
agent
elev
ph
acid
organel
thu
block
endocytosi
found
compar
mocktreat
cell
chloroquineand
bafilomycin
cell
increas
cell
viabil
treatment
figur
b
indic
endocytosi
involv
process
determin
caus
cell
death
via
endocytosi
next
attempt
elucid
specif
pathway
endocyt
pathway
virus
use
clathrindepend
independ
first
test
role
clathrinmedi
endocytosi
classic
clathrinmedi
endocyt
pathway
solubl
clathrin
cytoplasm
recruit
plasma
membran
clathrin
triskelia
assembl
polygon
lattic
form
coat
pit
bud
pinch
membran
give
rise
clathrinco
vesicl
cpz
caus
clathrin
assembl
endosom
membran
prevent
assembl
coat
pit
cell
surfac
thu
inhibit
clathrinmedi
endocytosi
found
pretreat
cell
cpz
could
rescu
cell
death
figur
suggest
clathrin
may
involv
process
howev
report
drug
target
specif
endocyt
pathway
may
pleiotrop
effect
may
specif
confirm
role
clathrinmedi
endocytosi
next
use
specif
sirna
approach
mention
clathrin
function
triskelion
threeleg
structur
assembl
three
heavi
chain
associ
light
chain
knockdown
heavi
chain
sirna
proven
effect
specif
method
assay
role
clathrinmedi
endocytosi
use
two
sirna
chc
determin
role
clathrinmedi
endocytosi
western
blot
show
sirna
effici
knockdown
chc
protein
figur
addit
sirna
treatment
significantli
enhanc
cell
viabil
treatment
inactiv
figur
result
suggest
enter
cell
via
clathrinmedi
endocytosi
report
addit
clathrinmedi
endocytosi
influenza
viru
also
enter
cell
via
caveolaemedi
endocytosi
caveola
flaskshap
invagin
cell
membran
compos
high
level
cholesterol
well
integr
membran
protein
caveolin
togeth
lipid
raft
caveola
cholesterolrich
microdomain
therefor
sequest
cholesterol
sterolbind
drug
nystatin
filipin
deplet
cholesterol
cell
membran
inhibit
caveolaemedi
endocytosi
analyz
whether
enter
cell
via
caveolaemedi
endocytosi
use
three
drug
specif
inhibit
pathway
effect
drug
caveolaemedi
endocytosi
examin
measur
uptak
ctb
sinc
target
caveola
uptak
block
kind
drug
figur
show
compar
mocktreat
cell
ctb
intern
within
cell
drugtreat
cell
show
inhibit
ctb
uptak
ctb
cluster
cell
surfac
indic
drug
work
well
cell
howev
drug
rescu
cell
death
figur
suggest
caveolaemedi
endocytosi
may
involv
entri
cell
viru
must
enter
host
cell
initi
life
cycl
entri
envelop
viru
endocytosi
direct
membran
fusion
phdepend
independ
respect
entri
influenza
viru
previous
studi
primarili
use
strain
due
increas
risk
outbreak
imper
elucid
specif
pathway
enter
human
host
cell
studi
use
human
lung
carcinoma
cell
line
found
enter
cell
via
clathrinmedi
endocytosi
determin
induc
cell
death
attempt
determin
could
rescu
cell
death
lysosomotrop
agent
proven
increas
cell
viabil
indic
may
caus
cell
death
endocytosi
acid
milieu
import
factor
endocytosi
lysosomotrop
agent
elev
ph
endosom
thu
inhibit
endocytosi
howev
note
although
report
yet
result
exclud
possibl
influenza
enter
cell
via
direct
membran
fusion
viru
may
employ
differ
pathway
enter
differ
cell
type
mani
factor
influenc
whether
viru
use
clathrindepend
clathrinindepend
endocytosi
among
natur
viru
doubt
import
factor
recent
studi
show
size
endocytos
particl
also
import
factor
determin
whether
clathrinor
caveolaemedi
endocytosi
use
studi
found
inhibitor
sirna
target
clathrin
pathway
could
rescu
cell
death
drug
inhibit
caveola
pathway
could
suggest
enter
cell
via
clathrinmedi
endocytosi
recent
report
fusion
peptid
ha
associ
cholesterol
rich
microdomain
support
data
neither
cholesterolbind
deplet
drug
inhibit
entri
howev
point
sara
et
al
possibl
novel
uncharacter
type
lipid
raft
may
involv
viru
uptak
particular
relationship
influenza
viru
lipid
raft
need
investig
although
research
point
specif
host
factor
may
requir
entri
host
cell
factor
still
identifi
suggest
lack
specif
influenza
viru
receptor
respons
mani
differ
entri
pathway
influenza
virus
use
enter
differ
cell
reason
possibl
like
enter
differ
cell
line
via
differ
endocyt
pathway
taken
togeth
data
indic
enter
cell
via
clathrinmedi
endocytosi
find
relev
develop
novel
therapeut
drug
target
influenza
viru
